Lanreotide (Deamidized) features one or more deamidated Asn or Gln residues, converting side chains to acidic forms. The modification shifts local charge, hydrogen-bonding capacity, and conformational preferences. Researchers use it to analyze degradation mechanisms and activity changes. Applications include stability testing, impurity characterization, and structure-function comparisons with native lanreotide.
CAT No: R2588
CAS No:150155-56-9
Synonyms/Alias:((4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-threonine; Lanreotide (Deamidized);150155-56-9;CHEMBL3350155;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.